ceritinib

Italy

Drugs containing this active substance

  • ZYKADIA

    It is used to treat adult patients with advanced stages of a type of lung cancer called non-small cell lung cancer (NSCLC), provided that the disease is caused by a defect in a gene called ALK.

    Form: capsules, hard gelatin

    Active substance Dosage
    ceritinib -

    ATC: L01ED02

    Manufacturer: NOVARTIS EUROPHARM LIMITED